Publications
- Effects of Treatment Change in Patients with Neovascular age-related Macular Degeneration; Results from the Czech National Registry2012 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form2011 | Faculty of Medicine in Hradec Králové
- Innovations in the Treatment of the Macular Edema in Retinal Venous Occlusions2011 | Faculty of Medicine in Hradec Králové
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration +12009 | Faculty of Medicine in Hradec Králové
- Intravitreous Bevacizumab (Avastin) in neovascular age related macular degeneration (pilot study) +1Publication without faculty affiliation
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Diabetic Macular Edema - Diagnostics and Treatment Guidelines2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Retina2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial2023 | Central Library of Charles University, Third Faculty of Medicine
Loading network view...